TOMMASINI, Silvana
 Distribuzione geografica
Continente #
NA - Nord America 3.902
EU - Europa 3.292
AS - Asia 774
SA - Sud America 9
OC - Oceania 8
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.993
Nazione #
US - Stati Uniti d'America 3.890
IE - Irlanda 1.006
SE - Svezia 838
CN - Cina 547
UA - Ucraina 490
DE - Germania 318
FI - Finlandia 168
GB - Regno Unito 166
IT - Italia 145
VN - Vietnam 140
IN - India 59
AT - Austria 50
PL - Polonia 28
RU - Federazione Russa 26
BE - Belgio 17
IR - Iran 15
FR - Francia 13
CA - Canada 9
CL - Cile 8
AU - Australia 7
RS - Serbia 5
CZ - Repubblica Ceca 4
EU - Europa 4
IQ - Iraq 4
EG - Egitto 3
RO - Romania 3
ES - Italia 2
IL - Israele 2
MX - Messico 2
NL - Olanda 2
TR - Turchia 2
AL - Albania 1
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
JP - Giappone 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
SG - Singapore 1
TH - Thailandia 1
Totale 7.993
Città #
Dublin 1.006
Jacksonville 946
Chandler 659
Nyköping 502
Beijing 208
Dearborn 203
Princeton 166
Ashburn 164
Cambridge 161
Medford 152
Dong Ket 140
Des Moines 118
Boardman 109
Ann Arbor 83
Lancaster 69
Messina 64
Jinan 58
Woodbridge 51
Vienna 50
Wilmington 49
San Mateo 41
Shenyang 40
Pune 37
Tianjin 30
Warsaw 28
Nanjing 26
New York 25
Hangzhou 24
Augusta 21
Bremen 20
Haikou 19
Nanchang 19
Leawood 18
Brussels 17
Hebei 14
Zhengzhou 13
Helsinki 12
Ningbo 12
Ardabil 11
Los Angeles 10
Edinburgh 9
Taiyuan 9
Auburn Hills 8
Fuzhou 8
Houston 8
Hyderabad 8
Jiaxing 8
Norwalk 8
Ottawa 8
Saint Petersburg 8
Seattle 8
Taizhou 8
Francofonte 7
Guangzhou 7
Monmouth Junction 7
Washington 7
Agrigento 6
Clearwater 6
Belgrade 5
Kunming 5
Las Vegas 5
Viagrande 5
Brno 4
Bangalore 3
Cairns 3
Cairo 3
Catania 3
Changsha 3
Hefei 3
Lanzhou 3
Milan 3
Mountain View 3
Mumbai 3
Phoenix 3
Rome 3
Tomsk 3
Xiangfen 3
Boston 2
Gravina di Catania 2
Kemerovo 2
La Canada Flintridge 2
Lappeenranta 2
London 2
Mortegliano 2
Naples 2
Nocera Inferiore 2
Novokuznetsk 2
Palermo 2
Perth 2
Piazza Armerina 2
Redmond 2
Santiago 2
Tappahannock 2
Tel Aviv 2
Turin 2
Ankara 1
Atlanta 1
Auckland 1
Bari 1
Brooklyn 1
Totale 5.640
Nome #
{ [1.1.1.] CRYPTAND/THYMOL BLUE } : A PROTOTYPE OF MOLECULAR APPARATUS FOR SPECTROPHOTOMETRIC AUTOMATIC STUDIES 155
{[1.1.1.]CRYPTAND/THYMOL BLUE}: A PROTOTYPE OF MOLECULAR APPARATUS FOR SPECTROPHOTOMETRIC AUTOMATIC STUDIES ON PH-RATE PROFILE OF DRUGS 130
Nanospheres based on PLGA/amphiphilic cyclodextrin assemblies as potential enhancers of Methylene Blue neuroprotective effect 97
Isoflavone Aglycons-Sulfobutil Ether-beta-Cyclodextrin Inclusion Complexes: in Solution and Solid State Studies 79
Analysis of the thermal fluctuations in inclusion complexes of genistein with β-cyclodextrin derivatives 78
SPETTRI DI RIFLESSIONE DI FLAVONOIDI DEDOTTI MEDIANTE TRASFORMATA DI KUBELKA-MUNK . 72
ENANTIOSEPARATION AND COMPLEXATION STUDIES ON 2,3-BENZODIAZEPINES 71
CARATTERIZZAZIONE DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE MEDIANTE:DSC,RAGGI X,DRIFT,UV-VIS 70
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 70
METHODS FOR PARTICLE SIZE DETERMINATION IN POWDERS OF PHARMACEUTICAL INTEREST. Nota II 68
TECNICHE CHEMOMETRICHE PER L'OTTIMIZZAZIONE DI METODOLOGIE STRUMENTALI IN ANALISI FARMACEUTICA 68
Analytical profile and release of lonidamine from pharmaceutical formulation 68
“Host-guest” interactions in Captisol®/Coumestrol inclusion complex: UV-vis, FTIR-ATR and Raman studies 68
Acyclovir-b-cyclodextrin prodrugs: an in vitro evaluation for oral administration”. 67
DETERMINATION OF FLAVONOIDS BY TURBIDIMETRIC MEASUREMETS 66
COMPARATIVE PHOTODEGRADATION STUDIES: INFLUENCE OF DIFFERENT MEDIA AND LIGHT SOURCES 64
CORDIA FRANCISCI, C, MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES AS NEW SOURCES OF RUTIN: ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY. 64
Direct separation of the enantiomers of reboxetine by liquid chromatography on different cellulose- and amylose-based chiral stationary phases 63
Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin 63
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 63
PREPARATION AND CHARACTERIZATION OF GEMCITABINE-LOADED CHITOSAN MICROSPHERES. 63
Nanotherapeutics for anti-inflammatory delivery 63
Anticonvulsant agent: enhancement of physicochemical properties 62
Comparative photodegradation studies on 3-hydroxyflavone: influence of different media, pH and light sources 62
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 62
Chitosan nanospheres containing cyclodextrins for idebenone delivery 62
Study of beta-blockers/beta-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigation 61
REAZIONI UV-INDOTTE:FOTOCHIMICA DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE. Nota II 61
OPTIMIZED ENANTIOSELECTIVE HPLC METHOD FOR THE ANALYSIS OF TETRAHYDROISOQUINOLINES 61
Preparation, characteristics and biological evaluation of micro and nanostructured carriers for controlled release 61
HPLC DIASTEREO ED ENANTIOSELETTIVA DI 2-ARIL-4-TIAZOLIDINONI SOSTITUITI. 61
UV-INDUCED REACTIONS:EFFECTS OF MICROENVIROMENT ON FLAVONOIDS PHOTOCHEMISTRY 60
A STUDY OF THE INCLUSION COMPLEX OF ATENOLOL WITH BETA-CYCLODEXTRIN 60
CORDIA FRANCISCI, C. MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES: A NEW SOURCES OF RUTIN. ANALGESIC AND ANTIINFLAMMATORY ACTIVITY 60
Study of the extraction procedure by experimental design and validation of a LC method for determination of flavonoids in Citrus bergamia juice 59
Rutin-Loaded Solid Lipid Nanoparticles: Characterization and In Vitro Evaluation 59
MOLECULAR MODELING OF ENANTIOSELECTIVE RECOGNITION BETWEEN GAMMA-LACTAMIC DERIVATIVES AND CHIRALCEL OD CHIRAL STATIONARY PHASE. 58
An experimental design methodology applied to the enantioseparation of a non-steroidal anti-inflammatory drug candidate 58
B-Cyclodextrin conjugates for sustained release of drugs 58
Photochemistry of flavonoids. Solvent effect on photochemical behaviour of 3-hydroxyflavone. 58
CHROMATOGRAPHIC INVESTIGATIONS ON BROTIZOLAM 58
CHITOSAN/SULFOBUTHYL ETHER BETA-CYCLODEXTRIN NANOPARTICLES FOR IDEBENONE DELIVERY 58
DIRECT ENANTIOMERIC SEPARATION OF REBOXETINE BY LIQUID CHROMATOGRAPHY USING DIFFERENT CELLULOSE AND AMYLOSE BASED CHIRAL STATIONARY PHASES 57
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 57
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 57
Diastereo-enantioseparation of N-Acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives on cellulose chiral stationary phases 56
STRUCTURAL AND CONFORMATIONAL STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN COMPLEXES 56
CONFORMATIONAL SEARCH OF PHENYL SUBSTITUTED GAMMA-LACTAMIC DERIVATIVES. 55
Amphiphilic beta-cyclodextrin nanoparticles encapsulating a carotenoid for drug delivery 55
A characterization study of resveratrol/sulfobutylether-b-cyclodextrin inclusion complex andin vitro anticancer activity 55
AN EXPERIMENTAL DESIGN METHODOLOGY APPLIED TO THE CHIRAL SEPARATION OF A NON-STEROIDAL ANTI-INFLAMMATORY DRUG CANDIDATE 54
Biodegradable microparticles as carrier for moxifloxacine 54
IMPROVEMENT OF FLAVONOIDS DISSOLUTION PROPERTIES BY COMPLEXATION WITH BETA-CYCLODEXTRIN 54
Study of flavonoids/beta-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation 52
HYDRATATION EFFECT ON THE MICELLAR STRUCTURE OF TRI-BLOCK COPOLYMER IN WATER (VISCOELASTIC RESULTS). 52
Temperature-dependent dynamical evolution in coum/sbe-β-cd inclusion complexes revealed by two-dimensional ftir correlation spectroscopy (2d-cos) 52
VALIDATION OF A LIQUID CROMATOGRAPHIC METHOD FOR THE ANALYSIS OF ZAFIRLUKAST IN A PHARMACEUTICAL FORMULATION 51
HPLC-DAD AND TLC OF FLAVONOIDS FROM LEAF EXTRACTIVES OF GENUS CORDIA. 51
The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrin 51
BROTIZOLAM: ANALISI E DETERMINAZIONE MEDIANTE TECNICHE CROMATOGRAFICHE. 51
ENANTIOMERIC RESOLUTION: HPLC ON CHIRAL STATIONARY PHASE OF ANTI-HIV AGENTS. 51
PHARMACEUTICAL APPLICATION OF BETA-CYCLODEXTRIN: INCLUSION COMPLEXES WITH BETA-BLOCKERS 51
RUTIN INCLUSION SYSTEMS WITH ALFA AND BETA-CYCLODEXTRINS: CIRCULAR DICHROISM, UV ABSORPTION SPECTROSCOPY AND ANTIOXIDANT ACTIVITY STUDIES 51
ANTIINFLAMMATORY ACTIVITY OF PLANTS IN TRADITIONAL MEDICINE: CORDIA MYXA L., C. FRANCISCI TEN., C. SERRATIFOLIA H.B.K. 51
Solid-state study of polymorphic drugs: carbamazepine 50
COMBINED EFFECT OF pH AND CYCLODEXTRINS ON SOLUBILIZATION OF NARINGENIN 50
INCLUSION COMPLEXES OF SOME FLAVANONES AND THEIR GLYCOSIDES WITH MODIFIED BETA-CYLODEXTRINS 50
Effects of alpha and beta-cyclodextrin complexation on the physico-chemical properties and antioxidant activity of some 3-hydroxyflavones 50
ENANTIOMERIC SEPARATION BY HPLC OF FLAVANONES AND FLAVANS WITH ANTIOXYDANT ACTIVITY. 50
STUDIO COMPARATIVO DI RISOLUZIONE ENANTIOMERICA DI NUOVI DERIVATI 2,3-BENZODIAZEPINICI AD ATTIVITA' ANTICONVULSIVANTE SU FASI STAZIONARIE CHIRALI DI NATURA POLISACCARIDICA. 50
FLUORIMETRIC STUDY OF b-BLOCKERS/b-CYCLODEXTRINS INCLUSION COMPLEXES 49
The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays 49
Determination of fludarabine in a pharmaceutical formulation by LC 49
Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin 49
Gemcitabine-loaded chitosan microspheres. Characterization and biological in vitro evaluation 49
Diastereo-enantioseparation of novel gamma-lactamic derivatives on cellulose chiral stationary phases 48
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 48
Gemcitabine-Loaded Chitosan Microspheres For Local Delivery In Lung, 48
PLGA/AMPHIPHILIC CYCLODEXTRIN NANOPARTICLES LOADING METHYLENE BLUE FOR NOSE-TO-BRAIN TARGETING IN ALZHEIMER'S DISEASE 48
STRUCTURAL AND THERMODYNAMIC STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN INCLUSION COMPLEXES 47
MODIFIED CYCLODEXTRINS IN THE SOLUBILIZATION OF SOME PHYTOESTROGENS 47
SPECTROSCOPIC STUDIES ON THE QUERCETIN/(2-HYDROXYPROPYL)-B-CYCLODEXTRIN INTERACTIONS 47
THE COORDINATION CHEMISTRY OF 1,4 BENZODIAZEPINES.HEAVY METAL COMPLEXES OF PSYCOTHERAPEUTIC DRUGS. 47
METODI PER LA VALUTAZIONE DIMENSIONALE DI PARTICELLE DI POLVERI DI IMPIEGO FARMACEUTICO.Nota IV. 47
Optimization of a LC method for the enantio separation of a non-competitive glutamate receptor antagonist, by experimental design methodology 47
HPLC DIASTEREO ED ENANTIOSELETTIVA DI 2-ARIL-4-TIAZOLIDINONI SOSTITUITI. 47
SINTESI DI DERIVATI FLAVONOIDICI A POTENZIALE ATTIVITA' ANTIVIRALE ED ANTITUMORALE 47
BETA-CYCLODEXTRIN CONJUGATES FOR SUSTAINED RELEASE OF DRUGS 46
ENANTIOMERIC SEPARATION BY HPLC OF FLAVANONES AND FLAVANS WITH ANTIOXYDANT ACTIVITY. 46
STRUCTURE OF BETA-BLOCKERS/BETA-CYCLODEXTRIN INCLUSION COMPLEX BY NMR, X-RAY AND DSC INVESTIGATION 45
Risoluzione cromatografica di gamma-lattami su fasi stazionarie chirali a base polisaccaridica. 45
ISOFLAVONES AND CYCLODEXTRINS: EVIDENCES OF COMPLEXATION BY COMPLEMENTARY SPECTROSCOPIC TECHNIQUES 45
STUDY OF THE EXTRACTION PROCEDURE BY EXPERIMENTAL DESIGN AND VALIDATION OF A LC METHOD FOR DETERMINATION OF FLAVONOIDS IN CITRUS BERGAMIA JUICE 44
HPLC DETERMINATION OF FLAVONOIDS CONTENT IN BERGAMOT JUICE 44
GEMCITABINE-LOADED CHITOSAN MICROSPHERES FOR LOCAL DELIVERY IN LUNG 44
DETERMINAZIONE DELLA STABILITA' DI PRODOTTI DI INTERESSE FARMACEUTICO. 44
MODELLO DI INTERAZIONE SELECTORS-SELCTANDS NEL PROCESSO DI DISCRIMINAZIONE CHIRALE. 44
CHIRAL RECOGNITION AND COMPLEXATION BEHAVIOUR OF BETA-CD vs. L- AND D,L-SERINE BY FTIR-ATR SPECTROSCOPY 44
Validation of a LC method for the analysis of oxaliplatin in a pharmaceutical formulation using an experimental design 43
LC/MS SELECTIVE SCREENING OF SOME BETA-BLOCKERS IN HUMAN URINE SAMPLES AND ITS POTENTIAL USE IN DOPING CONTROL 43
Totale 5.733
Categoria #
all - tutte 28.146
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.146


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20196 0 0 0 0 0 0 0 0 0 0 0 6
2019/20201.477 287 134 10 120 0 189 198 161 18 131 214 15
2020/20211.215 151 4 263 35 24 139 8 136 34 110 129 182
2021/20221.116 26 203 16 31 20 2 86 50 5 127 207 343
2022/20232.942 221 213 141 203 266 280 62 172 1.244 17 98 25
2023/2024519 76 105 52 66 53 116 12 21 0 15 2 1
Totale 8.101